Franklin M. Berger - Jun 21, 2024 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Franklin M. Berger
Stock symbol
AVIR
Transactions as of
Jun 21, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 06:08 PM
Previous filing
Jun 21, 2024
Next filing
Dec 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVIR Restricted Stock Units Award $0 +29.6K $0.00 29.6K Jun 21, 2024 Common Stock 29.6K Direct F1, F2
transaction AVIR Stock Option (Right to Buy) Award $0 +41.2K $0.00 41.2K Jun 21, 2024 Common Stock 41.2K $3.44 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
F3 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.